Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers
Abstract Background Dyslipidemia in metabolic syndrome may introduce an underestimation of the risk for cardiovascular disease (CVD) using Low-Density Lipoprotein-Cholesterol (LDL-C) as a surrogate marker. Recently, non-High-Density Lipoprotein-Cholesterol (non-HDL-C), Apolipoprotein B (ApoB) and re...
Saved in:
Main Authors: | Helena Bergström (Author), Lena Ekström (Author), Anna Warnqvist (Author), Peter Bergman (Author), Linda Björkhem-Bergman (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β‐hydroxycortisol/cortisol
by: Helena Bergström, et al.
Published: (2021) -
Sex-Differences in Discontinuation of Statin Treatment in Cancer Patients the Year before Death
by: Gabriella Frisk, et al.
Published: (2021) -
Variations of Ghrelin and Obestatin Hormones During the Menstrual Cycle of Women of Different BMIs
by: Salem AM, et al.
Published: (2022) -
Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
by: Brott DA, et al.
Published: (2014) -
Menstrual Cycle
Published: (2019)